Expertise in
3
conditions

Pascal Pommier

Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Lyon, FR 

Overview

Pascal Pommier practices practicing medicine in Lyon, France.

Mr. Pommier is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Anal Cancer, Prostate Cancer, Colorectal Cancer, Prostatectomy, and Colostomy.

He is actively involved in clinical research, co-authoring 154 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Lyon, France
Other Locations
Paris, France
Angers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors
Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors
Enrollment Status: Recruiting
Publish Date: September 02, 2021
Intervention Type: Radiation
Study Phase: Not Applicable
European Phase III Study Comparing a Radiation Dose Escalation Using 2 Different Approaches : External Beam Radiation Therapy Versus Endocavitary Radiation Therapy With Contact X-ray Brachytherapy 50 kiloVolts (kV) for Patients With Rectal Adenocarcinoma
European Phase III Study Comparing a Radiation Dose Escalation Using 2 Different Approaches : External Beam Radiation Therapy Versus Endocavitary Radiation Therapy With Contact X-ray Brachytherapy 50 kiloVolts (kV) for Patients With Rectal Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Device, Drug, Radiation
Study Phase: Phase 3
Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
Phase III Trial Testing the Benefit of Intensity-modulated Radiotherapy With Weekly Replanifications Versus Intensity Modulated Radiotherapy With Only One Planification in Locally Advanced Oropharynx Carcinoma for Decreasing Xerostomia
Phase III Trial Testing the Benefit of Intensity-modulated Radiotherapy With Weekly Replanifications Versus Intensity Modulated Radiotherapy With Only One Planification in Locally Advanced Oropharynx Carcinoma for Decreasing Xerostomia
Enrollment Status: Completed
Publish Date: July 27, 2021
Intervention Type: Radiation
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
Enrollment Status: Completed
Publish Date: June 01, 2021
Intervention Type: Drug
Study Drug: Afatinib
Study Phase: Phase 3
View 4 Less Clinical Trials

154 Total Publications

Erratum to "External beam radiotherapy for prostatic cancers: 2025 update" [Cancer Radiother 29 (2025) 104777].
Erratum to "External beam radiotherapy for prostatic cancers: 2025 update" [Cancer Radiother 29 (2025) 104777].
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: February 17, 2026

Frequently Asked Questions about Pascal Pommier

Is Pascal Pommier a top-rated expert for Anal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Pascal Pommier is classified as an Distinguished expert for Anal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pascal Pommier participate in research or clinical trials?

Yes. Pascal Pommier has published 154 articles and abstracts on conditions like Anal Cancer. You can view a list of Pascal Pommier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pommier's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile